Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-25

FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Prochlorperazine Edisylate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

SUPPL AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)